The US Food and Drug Administration has granted approval to Bristol-Myers Squibb’s drug Cobenfy® (xanomeline and trospium ...
Shares of Establishment Labs Holdings Inc. (ESTA) were surging more than 21 percent in pre-market on Friday to $50.22, after its ...
The US Food and Drug Administration has approved the new drug Cobenfy, which is owned by pharmaceutical firm Bristol Myers ...
Announces completion of enrollment in its oral allergen challenge study for the development of its late-stage pipeline program, Anaphylm™ (epinephrine) Sublingual FilmOutlines the development strategy ...
The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.
The FDA announced that it has accepted the supplemental sNDA for roflumilast foam 0.3% in those with scalp and body psoriasis over 12.
Hundreds of foods are recalled by the FDA every year. Food recalls could fall into different categories, depending on how ...
Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This ...
The Bristol Myers Squibb medicine is said relieve symptoms without causing some of the harsh side effects of drugs already in use. Meanwhile, thousands of patients allege in a lawsuit that drugs used ...
The U.S. Food & Drug Administration has accepted Aptar Pharma's N-Sorb nitrosamine mitigation solution into its Emerging ...
The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and ...
The gene therapy comes seven years after another research group at the university helped come up with the first FDA approved gene therapy for an inherited disease.